Patents by Inventor Paul L. Prather

Paul L. Prather has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of the aminoalkylindole JWH-073-M4 and related compounds as neutral CB1 receptor antagonists for the treatment of alcoholism, drug abuse, obesity, and obesity-related diseases
    Patent number: 9416103
    Abstract: Novel alkylindoles that bind tightly to cannabinoid receptors and are neutral antagonists for the cannabinoid 1 receptor and agonists for the cannabinoid 2 receptor are provided. These compounds are useful for treating alcoholism and drug abuse and for treating obesity.
    Type: Grant
    Filed: January 8, 2013
    Date of Patent: August 16, 2016
    Assignees: The Board of Trustees of the University of Arkansas, The University of Kansas
    Inventors: Paul L. Prather, Thomas E. Prisinzano, William E. Fantegrossi, Lisa K. Brents, Jeffery Moran, Anna Radominska-Pandya, Tamara Vasiljevik
  • Stilbenoid Derivatives And Their Uses
    Publication number: 20150328243
    Abstract: The present invention generally provides stilbenoid derivatives and methods for using stilbenoid derivatives to modulate the activity of cannabinoid receptors or scavenge reactive nitrogen species.
    Type: Application
    Filed: May 26, 2015
    Publication date: November 19, 2015
    Inventors: Anna Radominska-Pandya, Paul L. Prather, Luis Fabricio Medina-Bolivar, Philip R. Mayeux
  • USE OF THE AMINOALKYLINDOLE JWH-073-M4 AND RELATED COMPOUNDS AS NEUTRAL CB1 RECPTOR ANTAGONISTS FOR THE TREATMENT OF ALCOHOLISM, DRUG ABUSE, OBESITY, AND OBESITY-RELATED DISEASES
    Publication number: 20150266820
    Abstract: Novel alkylindoles that bind tightly to cannabinoid receptors and are neutral antagonists for the cannabinoid 1 receptor and agonists for the cannabinoid 2 receptor are provided. These compounds are useful for treating alcoholism and drug abuse and for treating obesity.
    Type: Application
    Filed: January 8, 2013
    Publication date: September 24, 2015
    Inventors: Paul L. Prather, Thomas E. Prisinzano, William E. Fantegrossi, Lisa K. Brents, Jefferey Moran, Anna Radominska-Pandya, Tamara Vasiljevik
  • Stilbenoid derivatives and their uses
    Patent number: 9095598
    Abstract: The present invention generally provides stilbenoid derivatives and methods for using stilbenoid derivatives to modulate the activity of cannabinoid receptors or scavenge reactive nitrogen species.
    Type: Grant
    Filed: December 28, 2011
    Date of Patent: August 4, 2015
    Assignees: The Board of Trustees of the University of Arkansas, Arkansas State University—Jonesboro
    Inventors: Anna Radominska-Pandya, Paul L. Prather, Luis Fabricio Medina-Bolivar, Philip R. Mayeux
  • CB2 Receptor Modulators in Neurodegenerative Diseases and Applications of the Same
    Publication number: 20130303528
    Abstract: Compositions for the treatment of neurodegenerative diseases are disclosed. Methods of treating and monitoring progression of a neurodegenerative disease are disclosed. According to the present invention, a selective CB2 receptor modulator may be administered to a mammal for the treatment of a neurodegenerative disease.
    Type: Application
    Filed: March 29, 2013
    Publication date: November 14, 2013
    Inventors: Paul L. Prather, John P. Crow
  • STILBENOID DERIVATIVES AND THEIR USES
    Publication number: 20120165281
    Abstract: The present invention generally provides stilbenoid derivatives and methods for using stilbenoid derivatives to modulate the activity of cannabinoid receptors or scavenge reactive nitrogen species.
    Type: Application
    Filed: December 28, 2011
    Publication date: June 28, 2012
    Applicants: ARKANSAS STATE UNIVERSITY - JONESBORO, The Board of Trustees of the University of Arkansa
    Inventors: Anna Radominska-Pandya, Paul L. Prather, Luis Fabricio Medina-Bolivar, Philip R. Mayeux
  • CB2 Receptor Modulators In Neurodegenerative Diseases And Applications Of The Same
    Publication number: 20090124608
    Abstract: Compositions for the treatment of neurodegenerative diseases are disclosed. Methods of treating and monitoring progression of a neurodegenerative disease are disclosed. According to the present invention, a selective CB2 receptor modulator may be administered to a mammal for the treatment of a neurodegenerative disease.
    Type: Application
    Filed: October 5, 2007
    Publication date: May 14, 2009
    Applicant: Board of Trustees of the University of Arkansas
    Inventors: Paul L. Prather, John P. Crow